Skip to main content
Drugwatch.com
  • Active Lawsuits
    • Lawsuits Directory
      • Prescription Drug Lawsuits
        • Depo-Provera Lawsuit
        • Dupixent Lawsuit
        • Ozempic Lawsuit
        • Suboxone Lawsuit
        • Tylenol Autism & ADHD Lawsuits
      • Product Lawsuits
        • Hair Relaxer Lawsuit
        • Baby Formula NEC Lawsuit
        • Paraquat Lawsuit
        • Roundup Lawsuit
        • Talcum Powder Lawsuit
      • Medical Device Lawsuits
        • Bard PowerPort Lawsuit
        • FreeStyle Libre 3 Glucose Monitor Lawsuit
        • Hernia Mesh Lawsuit
        • Hip Replacement Lawsuit
        • Olympus Scope Lawsuit
        • Spinal Cord Stimulator Lawsuit
        • Transvaginal Mesh Lawsuit
      • Chemical Exposure Lawsuits
        • PFAS Lawsuit
        • Aqueous Film-Forming Foam (AFFF) Lawsuit
        • PFAS Firefighter Gear Lawsuit
    • Injured by a prescription drug or defective medical device?
      Get a Free Case Review
  • Latest Legal News
    • News
    • Judge holding gavel in courtroom
      Latest News
      Tylenol Lawsuit 2026 Update: Appeals Court Reignites Autism Claims
      July 15, 2026
      Hernia Mesh Being Handled by Surgeons
      Latest News
      Key Covidien Hernia Mesh Lawsuit Trial Begins With Thousands of Other Cases Waiting
      July 14, 2026
      Statue of justice with judge and gavel
      Latest News
      What’s New in Dangerous Product Lawsuits in July 2026
      July 9, 2026
    • Drugwatch Investigations
    • Featured Article
      Big Tech on Trial: Inside the Social Media Addiction Lawsuits
    • Plaintiff Stories
    • Drugwatch Placeholder
      Latest Story
      Pennsylvania Woman Had Multiple ER Trips After Ongoing Ozempic Gastrointestinal “Attacks”
  • High-Risk Drugs & Devices
    • Drugs
      • Depo-Provera
      • Dupixent
      • Mounjaro (Tirzepatide)
      • Ozempic (Semaglutide)
      • Tepezza
      • Truvada
      • Tylenol (Acetaminophen)
    • Devices
      • Allergan Breast Implants
      • Bard PowerPort
      • FreeStyle Libre Sensors
      • Hernia Mesh
      • Hip Replacements
      • IVC Filters
      • Olympus Scopes
      • Paragard
      • Spinal Cord Stimulators
      • Transvaginal Mesh
  • Who We Are
    • About Drugwatch
      • Our Team
        • Awards & Accreditations
        • Client Reviews
        • Video Library
      • Our Trusted Legal Partners
        • Attorney Q&As
        • Drugwatch Editorial Policy
        • Press Room
    • Our Legal Experts
      • Brendan McDonough, Weitz & Luxenberg attorney
        Brendan A. McDonough, Esquire Associate Attorney, Drug & Medical Device Litigation
      • Headshot of attorney Jonathan Sedgh
        Jonathan M. Sedgh, Esquire Mass Tort & Product Liability Attorney
      • Jayne Conroy, Named Shareholder of Simmons Hanly Conroy
        Jayne Conroy, Esquire Trial Attorney and Pharmaceutical Litigation Expert
      • Headshot of attorney, Trent Miracle.
        Trent B. Miracle, Esquire Mass Tort and Product Liability Attorney
SPEAK WITH AN EXPERT
Call Now (888) 645-1617 Who Am I Calling?
(888) 645-1617Call Now
click to open search box
Brought To You By The Wilson Firm LLP

Lawsuit News

New study links talc and ovarian cancer.
Lawsuit News New Study Shows ‘Positive Association’ Between Talc, Ovarian Cancer
A new study from the National Institutes of Health has found a “consistent association” between the use of talcum powder in the genital area and an increased risk of ovarian cancer. The findings may benefit the thousands of people suing Johnson & Johnson, who claim the company’s Johnson’s…
May 20, 2024
Read More
  • Johnson & Johnson Talcum Powder
    Johnson & Johnson Proposes $6.48 Billion Settlement To Resolve Talc Lawsuits
    May 2, 2024
  • Johnson & Johnson Logo
    Johnson & Johnson, Kenvue Hit With $45 Million Talc Judgment
    April 30, 2024
  • Cpap machine on bedside
    Philips Agrees to $1.1B Settlement Over Faulty CPAP Breathing Machines
    April 29, 2024
  • Spraying weed killer
    Bayer Lobbyists Push for Protection from Cancer Claims
    April 24, 2024
  • Man spraying weed killer
    Court Slashes Bayer’s $1.56 Billion Roundup Verdict
    April 9, 2024
Previous
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 54
Next

Featured Articles

More

Personal Stories

More
Who Am I Calling?

Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.

Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(888) 645-1617
Get A Free Case Review

Injured by a drug, medical device or product? You may be entitled to compensation. Speak with an experienced attorney at no cost or obligation.

See If You QualifySee If You Qualify
Navigate
  • Lawsuits
  • FDA
  • News
  • Drugs
  • About Us
  • Health Info
  • Devices
  • Drugwatch Podcast
  • Side Effects
  • Beyond Side Effects
Drugwatch.com

Help for people injured by defective drugs and medical devices

More About Us
  • (888) 645-1617 Who Am I Calling?
  • Connect with Drugwatch on Facebook
  • Connect with Drugwatch on Twitter
  • Connect with Drugwatch on Youtube
  • Contact Drugwatch by Email
  • Click for the BBB Business Review of Drugwatch.com, LLC
  • AMWA Member Logo
  • APHA Logo
  • AACI Logo

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

© 2026 Drugwatch.com Privacy Policy /

California Consumer Privacy Act (CCPA) Inquiries

Drugwatch.com doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.

Sorry there was an error. Please wait a moment and try again.
Sorry there is a continuing error in our system. Please call us using the phone number listed on this page.

We value your privacy. By clicking REVIEW MY CASE, you agree to our privacy policy and disclaimer. After submitting, you will be contacted by one or more of Drugwatch's trusted legal partners (including autodialed and prerecorded calls or text/SMS messages). Msg. and data rates apply. Your consent to text messaging is not required for a case review and you may opt out of text messages at any time by texting STOP. This is legal advertising.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617